Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: Bupropion for the Prevention of Postpartum Smoking Relapse [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating whether bupropion can prevent postpartum smoking relapse and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • bupropion (bupropion)

Snippet

Sponsor: University of Minnesota | Conditions: Postpartum Smoking Relapse | Phase 4 | Status: RECRUITING